Drug Tissue Binding

Drug Tissue Binding is a pharmacokinetic process in which a drug reversibly associates with components of bodily tissues, distinguishing it from plasma protein binding by involving extracellular matrix, cellular structures, or specific tissue-resident molecules that sequester the drug outside the vascular compartment.

220

Publications

9.7K

Citations

732

Authors

238

Institutions

Publications per year

2017–2026

27

Authors

732

  1. MA
    Mark A. Lovich

    St. Elizabeth's Medical Center, United States

    4 publications · 372 citations

    4

    h-index

  2. WJ
    William J. Jusko

    University at Buffalo, State University of New York, United States

    4 publications · 84 citations

    4

    h-index

  3. HK
    Herbert Kurz

    Medical University of Vienna, Austria

    4 publications · 131 citations

    4

    h-index

  4. KV
    Klára Valkó

    GlaxoSmithKline (United Kingdom), United Kingdom

    4 publications · 136 citations

    4

    h-index

  5. ER
    Elazer R. Edelman

    Massachusetts Institute of Technology, United States

    4 publications · 372 citations

    4

    h-index

1–5 of 732

Venues

  1. PubMed

    Repository · 19 publications · 715 citations

    14

    h-index

  2. 12

    h-index

  3. Drug Metabolism and Disposition

    11 publications · 422 citations

    10

    h-index

  4. Journal of Pharmaceutical Sciences

    9 publications · 333 citations

    9

    h-index

  5. European Journal of Clinical Pharmacology

    7 publications · 559 citations

    7

    h-index

1–5